Previous studies of our group have shown that CHAF1A acts as a growth promoting agent in epithelial ovarian cancer, and its high expression is associated with clinical stage and lymph node metastasis, which can promote cancer cells proliferation and inhibit cancer cells apoptosis [7]. Here, CHAF1A is linked to ovarian carcinoma.